Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 3Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 7Thoracic 2Head & Neck 2Genitourinary 2Other 1NET 1Dermatologic 1CNS 1Breast 1

Conditions

Melanoma 488Lymphoma, T-Cell, Cutaneous 92Carcinoma, Non-Small-Cell Lung 89Mycosis Fungoides 72Neoplasm Metastasis 71Skin Neoplasms 62Neoplasms 61Sezary Syndrome 60Carcinoma, Renal Cell 60Lymphoma, Non-Hodgkin 53Lymphoma, Large B-Cell, Diffuse 53Lymphoma 53Breast Neoplasms 52Leukemia, Lymphocytic, Chronic, B-Cell 50Lymphoma, Follicular 47Lymphoma, Mantle-Cell 46Lymphoma, B-Cell, Marginal Zone 46Squamous Cell Carcinoma of Head and Neck 45Precursor Cell Lymphoblastic Leukemia-Lymphoma 44Hodgkin Disease 44Colorectal Neoplasms 43Burkitt Lymphoma 43Lymphoma, Large-Cell, Immunoblastic 41Ovarian Neoplasms 38Multiple Myeloma 35Uveal Melanoma 34Leukemia, Hairy Cell 33Lymphoma, Large-Cell, Anaplastic 32Sarcoma 31Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 31

Interventions

pentetreotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Gastrinoma × Dermatologic × Clear all
NCT00002947 2014-07-02

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Yale University

Phase 1 Terminated
35 enrolled
CNSDermatologicEndocrineGenitourinaryHead & NeckThoracic

Uveal Melanoma, Carcinoma, Renal Cell, Vipoma, Glucagonoma, Head and Neck Neoplasms, Insulinoma, Adenoma, Islet Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Pheochromocytoma, Somatostatinoma, Carcinoma, Merkel Cell, Gastrinoma, Central Nervous System Neoplasms, Carcinoma, Islet Cell, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡